Investigation of adverse effects and healing factor properties of a novel formulation from Blue-O Medical Technology

The appearance of multidrug resistance of pathogens is
challenging the researcher and industrial communities to develop more efficacious
antimicrobial treatments. Blue-O Technology Incorporation (Blue-O Tech) has developed
a novel formulation of medicine that accelerates the wound healing, while having an
excellent antimicrobial strength over a broad spectrum of pathogens. The objectives of
this study are to evaluate the cytotoxic effects, the immunological response, and the
healing properties of this novel medicine prior to its marketing and commercialization.

Faculty Supervisor:

Horacio Bach

Student:

Partner:

Blue-O Technology Inc.

Discipline:

Life Sciences

Sector:

University:

The University of British Columbia

Program:

Accelerate

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects